Mersana Therapeutics
MRSN
MRSN
48 hedge funds and large institutions have $70M invested in Mersana Therapeutics in 2018 Q4 according to their latest regulatory filings, with 9 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 6 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
48
Holders Change
+2
Holders Change %
+4.35%
% of All Funds
1.07%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
9
Increased
12
Reduced
15
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
$2.24M |
| 2 |
JG
Jefferies Group
New York
|
$1.37M |
| 3 |
ACH
ArrowMark Colorado Holdings
Denver,
Colorado
|
$8.27M |
| 4 |
JPMorgan Chase & Co
New York
|
$1.73M |
| 5 |
HP
Hikari Power
Tokyo,
Japan
|
$348K |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
$3.94M |
| 2 |
EC
EcoR1 Capital
San Francisco,
California
|
$0 |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
$1.09M |
| 4 |
Millennium Management
New York
|
$181K |
| 5 |
BlackRock
New York
|
$3.19M |
